Site içinde arama yapın

Naznin Shaikh bir ses eklendi Music
2026-03-09 08:28:44

CAR-T Cell Therapy Market Demand Rising Across Global Healthcare
Expanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...

0 Yorumlar 0 hisse senetleri 969 Views 0 önizleme

Please log in to like, share and comment!
KUMUD SINGH bir ses eklendi Health
2026-03-24 11:53:50

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Yorumlar 0 hisse senetleri 49 Views 0 önizleme

Please log in to like, share and comment!
Naznin Shaikh bir ses eklendi Causes
2026-03-10 10:11:49

Dendritic Cell Cancer Vaccine Market Opportunities in Precision Medicine
Pharmaceutical companies are expanding their oncology pipelines to include dendritic cell vaccine therapies. Continuous research is leading to the discovery of new therapeutic targets. These advancements are strengthening the market. The Dendritic Cell Cancer Vaccine Market is gaining significant attention in the global oncology landscape as immunotherapy continues to revolutionize cancer...

0 Yorumlar 0 hisse senetleri 869 Views 0 önizleme

Please log in to like, share and comment!
Mikel Watson bir ses eklendi Other
2026-03-04 12:44:21

Expanding Oncology Demand Boosts Immune Checkpoint Inhibitors Market Value
Immune checkpoint inhibitors are cutting-edge immunotherapies that strengthen the body’s natural defense mechanisms by inhibiting proteins that prevent immune cells from attacking cancer. By blocking checkpoints such as CTLA 4 and PD 1/PD L1, these treatments enhance T cell activation and tumor destruction. Their expanding clinical success is driving broader integration into combination...

0 Yorumlar 0 hisse senetleri 651 Views 0 önizleme

Please log in to like, share and comment!
Naznin Shaikh bir ses eklendi Health
2026-03-06 09:22:22

Investment Trends in the Anti-cancer Drugs Market
The increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...

0 Yorumlar 0 hisse senetleri 928 Views 0 önizleme

Please log in to like, share and comment!
Komal Galande bir ses eklendi Crafts
2026-03-12 08:01:20

Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?
Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...

0 Yorumlar 0 hisse senetleri 661 Views 0 önizleme

Please log in to like, share and comment!
Mikel Watson bir ses eklendi Other
2026-02-27 13:10:43

Neoantigens Market Forecast to Grow to US$ 5,607.32 Million by 2034
Neoantigens are newly formed antigenic determinants generated from cancer-specific DNA mutations that alter protein structure within tumor cells. These altered peptides are processed and presented on the tumor cell surface through major histocompatibility complex molecules, enabling targeted immune recognition. Their exclusivity to malignant cells positions them as powerful biomarkers and...

0 Yorumlar 0 hisse senetleri 949 Views 0 önizleme

Please log in to like, share and comment!